| Hans-Günter Meyer-Thompson | Hepatitiden
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A, Conen A, Knuchel J, Friedl A, Eigenmann F, Näf M, Ackle P, Roth M, Fux CA.
Swiss Med Wkly. 2017 Nov 29;147:w14544. doi: 10.4414/smw.2017.14544.